21 and older, any sex, with Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Shared Decision Making Process (SDMP) Scale ScorePrimary· About 1 week after the physician visit
The SDMP scale is a short, patient-reported scale that asks patients about discussion of options, pros and cons of colonoscopy and discussion of patients' preferences. Total scores range from 0-4, with higher scores indicating more shared decision making.
Group
Value
95% CI
Notification Only Arm/ Patients
1.1
± 1.2
Training and Notification Arm/ Patients
1.5
± 1.2
Patients' Colorectal Cancer Screening Knowledge ScoreSecondary· 1 week after physician visit
Colorectal Cancer (CRC) Screening Knowledge will be assessed with multiple choice knowledge items adapted from the CRC Decision Quality Instrument. A total score from 0-100% will be calculated based on the number of correct answers, with higher scores indicating higher knowledge.
Group
Value
95% CI
Notification Only Arm/ Patients
61
± 18.8
Training and Notification Arm/ Patients
63
± 17.7
Percentage of Patients Who Received Preferred Approach to Colorectal Cancer TestingSecondary· 1 week after physician visit (preference); 12 months after physician visit (testing)
Colorectal Cancer Screening Preference assessed with 1 item adapted from the CRC Decision Quality Instrument will be compared with the screening approach followed (assessed via chart review and patient report) to determine the percentage of patients who received preferred approach to testing.
Group
Value
95% CI
Notification Only Arm/ Patients
103
Training and Notification Arm/ Patients
115
Physician's Shared Decision Making SkillsSecondary· Baseline
The transcripts from the simulated patient interactions will be scored by two coders using Braddock's Informed Decision Making framework. Total scores range from 0-9 with higher scores indicating more shared decision making elements in the interaction.
Group
Value
95% CI
Notification Only Arm/Providers
5.5
± 1.3
Training and Notification Arm/ Providers
6.1
± 1.6
Colorectal Cancer Screening RatesSecondary· 1 year
The chart review results of cancer screening rates for patients enrolled in the study.
Group
Value
95% CI
Notification Only Arm/Patients
29.1
23.3 – 35.5
Training and Notification Arm/Patients
38.6
32.3 – 45.1
Clinician Satisfaction With the VisitSecondary· 1 week post visit
The percentage of study patient visits where the clinicians' reported that they were 'extremely or very satisfied' will be compared across arms.
Group
Value
95% CI
Notification Only Arm/Patient
138
Training and Notification Arm/Patient
171
Companion SDM Process Scale ScoreSecondary· About a week after physician visit
Companions will complete an adapted version of the SDM Process survey to provide a different perspective on the conversation and involvement of the patient. A total score will range from 0-4, with higher scores indicating more shared decision making.
The investigators will use five items to assess clinicians' confidence in Shared Decision Making Skills and Barriers to SDM. A total confidence score (0-20) with higher scores indicating higher confidence and a barrier score (0-8) higher scores indicating more barriers will be calculated.
Total Confidence
Group
Value
95% CI
Notification Only Arm/Providers
10.2
± 2.4
Training and Notification Arm/ Providers
10.7
± 1.8
Barrier Confidence
Group
Value
95% CI
Notification Only Arm/Providers
0.79
± 1.4
Training and Notification Arm/ Providers
0.88
± 1.57
Sponsor's own description
This project aims to examine the impact of different interventions designed to help individualize colorectal cancer (CRC) screening decisions in adults aged 76-85. Clinicians will be assigned by chance to one of two arms. In the Intervention arm, clinician participants will complete a training course and will also be notified of patients in the target age group who are due for a discussion about CRC screening. In the Comparator arm, clinician participants will be notified of their patients in the target age group with an upcoming visit who are due for a discussion about CRC screening. The investigators expect that patients seen by clinicians in the intervention arm will report more involvement in the decision making process, be more knowledgeable about the risks and benefits of CRC screening, and will have better quality decisions. Further, the investigators expect that the physicians in the intervention arm will have greater confidence in and demonstrate more skills for conducting shared decision making conversations as compared to those in the control arm.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
Other recruiting trials for Colorectal Cancer Screening
Currently open trials in the same condition.
NCT06757192 — CRC Screening in Unscreened Individuals 45-54
· recruiting
NCT06763432 — Positive Fit to Colonoscopy: Closing the Gap
· recruiting
NCT06821009 — Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
· NA
· recruiting
NCT06666556 — Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, M
· Phase 4
· recruiting
NCT07224750 — A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
· recruiting
Other Massachusetts General Hospital trials
Trials by the same sponsor.
NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
· withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg
· NA
· not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
· NA
· not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries
· NA
· not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation
· EARLY_PHASE1
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 6 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03959696.